- Report
- April 2024
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2024
- 170 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €3186EUR$3,500USD£2,706GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €3186EUR$3,500USD£2,706GBP
- Report
- October 2023
- 83 Pages
Israel
From €3186EUR$3,500USD£2,706GBP
- Report
- August 2023
- 75 Pages
Canada
From €3186EUR$3,500USD£2,706GBP
- Report
- August 2023
- 112 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- August 2023
- 74 Pages
United States
From €3186EUR$3,500USD£2,706GBP
- Report
- July 2023
- 77 Pages
Egypt
From €3186EUR$3,500USD£2,706GBP
- Report
- July 2023
- 78 Pages
Turkey
From €3186EUR$3,500USD£2,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 71 Pages
Italy
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 85 Pages
United States
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 69 Pages
United Kingdom
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 75 Pages
South Korea
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2022
- 134 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2022
- 116 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2022
- 110 Pages
Global
From €4323EUR$4,750USD£3,672GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more